Archive — US — techcrunch
Hinge Health pops 17%, but joins growing ranks of down-round IPOs
Hinge Health's shares surged 17% to $37.56 on its NYSE debut, though its valuation of $3 billion is significantly below its previous $6.2 billion private valuation from 2021. This trend of down-round IPOs is becoming more common, with the stigma waning since the 2020-2021 boom. Hinge aims to reduce musculoskeletal pain using wearable technology and remote monitoring.
Key points
- Hinge Health went public on the NYSE at $32, closing its first trading day at $37.56, representing a 17% increase.
- The company’s market cap post-IPO is approximately $3 billion, which is below its prior private valuation of $6.2 billion during a Series E funding round in October 2021.
- The trend of down-round IPOs is increasing, as evidenced by companies like Reddit and ServiceTitan, which also had initial valuations below their last private evaluations.
- Hinge Health's IPO raised $437 million, with $237 million going to the company and the rest to existing investors.
- Competitors in the market include Omada Health and Sword Health, with Sword considering a potential IPO in 2025.
Why it matters
- The rise of down-round IPOs reflects broader shifts in the market following the inflated valuations during the 2020-2021 tech boom.
- Hinge’s use of wearables and remote health monitoring aligns with ongoing IT trends focusing on digital health technologies and telemedicine.
- Other notable down-round IPOs like Reddit and ServiceTitan indicate growing acceptance of lower public valuations in today's valuation landscape, following major market corrections.
Hinge Health's successful IPO highlights both the demand for digital health solutions and the evolving sentiment toward down-round listings, suggesting a shift in investor expectations post-boom. The company’s innovative approach to physical therapy could mark a significant trend in healthcare technology.